RBC Capital lowered the firm’s price target on Thermo Fisher (TMO) to $637 from $651 and keeps an Outperform rating on the shares. The company lowered guidance to reflect the estimated impact from tariff and policy changes, though this lowers the likelihood of further cuts this year, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMO:
- Thermo Fisher price target lowered to $573 from $603 at Baird
- Thermo Fisher’s Resilience and Strategic Positioning Justify Buy Rating Despite Macroeconomic Challenges
- Thermo Fisher Scientific Reports Strong Q1 2025 Results
- Thermo Fisher Scientific Navigates Strong Q1 Amid Challenges
- Thermo Fisher price target lowered to $610 from $670 at Goldman Sachs